We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERICS QUESTION ABILITY OF OGD TO MEET DEMAND UNDER FLAT BUDGET
GENERICS QUESTION ABILITY OF OGD TO MEET DEMAND UNDER FLAT BUDGET
February 10, 2004
Some in the generic drug industry want the FDA’s Office of Generic Drugs (OGD) to put a hold on new rules, like requiring additional bioequivalency (BE) studies, if it becomes clear the agency isn’t able to handle an increasing workload with a Bush administration-proposed fiscal 2005 budget that keeps funding levels flat.